Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update